Logo image of CNTX

CONTEXT THERAPEUTICS INC (CNTX) Stock Analyst Ratings

NASDAQ:CNTX - Nasdaq - US21077P1084 - Common Stock - Currency: USD

0.814  +0.02 (+3.04%)

After market: 0.7855 -0.03 (-3.5%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to CNTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 7.22. This target is 787.59% above the current price.
CNTX was analyzed by 12 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about CNTX.
In the previous month the buy percentage consensus was at a similar level.
CNTX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
CNTX Historical Analyst RatingsCNTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -36 -33 -30 -27 -24 -21 -18 -15 -12 -9 -6 -3 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.814.047.147.2210.50 - 396.31% 777.15% 787.59% 1,189.93%
CNTX Current Analyst RatingCNTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-01-15 D. Boral Capital Maintains Buy -> Buy
2025-01-08 JMP Securities Initiate Market Outperform
2024-11-25 D. Boral Capital Initiate Buy
2024-09-23 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-16 Piper Sandler Initiate Overweight
2024-05-09 Maxim Group Maintains Buy -> Buy
2024-05-09 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-21 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-01 HC Wainwright & Co. Upgrade Neutral -> Buy
2023-09-11 Maxim Group Initiate Buy
2023-06-06 HC Wainwright & Co. Reiterate Neutral
2023-03-23 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-02-07 HC Wainwright & Co. Reiterate Buy
2022-02-02 HC Wainwright & Co. Initiate Buy
2022-01-24 ThinkEquity Initiate Buy